The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center, Inc. Announces The Initiation Of A 2 Year Phase 1 SBIR Grant With Advanced Neural Dynamics

 

Doylestown, PA. July 1, 2009 – The Fox Chase Chemical Diversity Center (FCCDC) today announced the initiation of a 2 year phase 1 SBIR grant with Advanced Neural Dynamics (AND), Doylestown, PA. In support of the grant entitled Novel Thioderivatives as Neuroprotective Anticonvulsants (1 R43 NS066537-01), FCCDC serves as the medicinal chemistry support team responsible for the design and synthesis of novel anticonvulsants which possess neuroprotective properties